MJFF Grants XingImaging SynuSight 18F-FD4 PET Tracer for Parkinson’s
September 11, 2025 | 19:20
US$1.2 million award accelerates first α-synuclein imaging agent, enabling early Parkinson’s diagnosis and boosting neurodegenerative drug trials.
XingImaging Opens State-of-the-Art Research Facility in New Haven, Connecticut
January 13, 2025 | 17:00
XingImaging, a MITRO company, a leader in advanced research imaging and radiopharmaceutical services, is excited to announce the opening of its new state-of-the art research facility in New Haven, Connecticut .
Mobile Version